TT-14

N/A

Report date: 2026/04/24 16:00:15

Base Information

Drug NameTT-14

Drug Alias NameGPC3-CAR VST(Tessa Therapeutics)TT-14

ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionT lymphocyte replacementsImmunologic cytotoxicity

TargetsUpdating

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySingapore

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesTessa Therapeutics Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTessa Therapeutics Ltd

Active IndicationsN/A

Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A